124 related articles for article (PubMed ID: 1782355)
1. Topographical requirements for delta-selective opioid peptides.
Nikiforovich GV; Hruby VJ; Prakash O; Gehrig CA
Biopolymers; 1991 Jul; 31(8):941-55. PubMed ID: 1782355
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
Wilkes BC; Schiller PW
Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
[TBL] [Abstract][Full Text] [Related]
3. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
Lomize AL; Pogozheva ID; Mosberg HI
Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255
[TBL] [Abstract][Full Text] [Related]
4. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.
Shenderovich MD; Liao S; Qian X; Hruby VJ
Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models.
Bryant SD; Attila M; Salvadori S; Guerrini R; Lazarus LH
Pept Res; 1994; 7(4):175-84. PubMed ID: 7696838
[TBL] [Abstract][Full Text] [Related]
6. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
[TBL] [Abstract][Full Text] [Related]
7. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the structural parameters involved in the delta-opioid selectivity of several families of opioid peptides.
Guis C; Bruetschy L; Meudal H; Roques BP; Gacel GA
Int J Pept Protein Res; 1993 Jun; 41(6):576-86. PubMed ID: 8394291
[TBL] [Abstract][Full Text] [Related]
9. Examination of the conformational meaning of "delta-address" in the dermenkephalin sequence.
Nikiforovich GV; Hruby VJ
Biochem Biophys Res Commun; 1990 Dec; 173(2):521-7. PubMed ID: 1979733
[TBL] [Abstract][Full Text] [Related]
10. Folding trends in a flexible peptide: two-dimensional NMR study of deltorphin-I, a delta selective opioid heptapeptide.
Duchesne D; Naim M; Nicolas P; Baron D
Biochem Biophys Res Commun; 1993 Sep; 195(2):630-6. PubMed ID: 8373402
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
[TBL] [Abstract][Full Text] [Related]
12. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
Shenderovich MD; Nikiforovich GV; Golbraikh AA
Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
[TBL] [Abstract][Full Text] [Related]
13. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
14. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
Nikiforovich GV; Kolodziej SA; Nock B; Bernad N; Martinez J; Marshall GR
Biopolymers; 1995 Oct; 36(4):439-52. PubMed ID: 7578939
[TBL] [Abstract][Full Text] [Related]
15. The delta-selective opioid peptide dermenkephalin and the mu-selective hybrid peptide dermenkephalin-[1-4]-dermophin-[5-7] display strikingly different conformations despite identical tetrapeptide N-termini. A quantitative 2-D NMR and molecular modeling analysis.
Riand J; Baron D; Nicolas P; Benajiba A; Teng Y; Naim M
J Biomol Struct Dyn; 1999 Dec; 17(3):445-60. PubMed ID: 10636080
[TBL] [Abstract][Full Text] [Related]
16. Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine.
Fox-Threlkeld JE; Daniel EE; Christinck F; Hruby VJ; Cipris S; Woskowska Z
J Pharmacol Exp Ther; 1994 Feb; 268(2):689-700. PubMed ID: 8113980
[TBL] [Abstract][Full Text] [Related]
17. Conformational determinants of high affinity delta receptor binding of opioid peptides.
Keys C; Payne P; Amsterdam P; Toll L; Loew G
Mol Pharmacol; 1988 May; 33(5):528-36. PubMed ID: 2835652
[TBL] [Abstract][Full Text] [Related]
18. Quantitative two-dimensional NMR study of dermenkephalin, a highly potent and selective delta-opioid peptide.
Naim M; Charpentier S; Nicolas P; Baron D
Biopolymers; 1993 Dec; 33(12):1889-900. PubMed ID: 8268413
[TBL] [Abstract][Full Text] [Related]
19. New insights on mu/delta selectivity of opioid peptides: conformational analysis of deltorphin analogues.
Tancredi T; Temussi PA; Picone D; Amodeo P; Tomatis R; Salvadori S; Marastoni M; Santagada V; Balboni G
Biopolymers; 1991 May; 31(6):751-60. PubMed ID: 1932571
[TBL] [Abstract][Full Text] [Related]
20. [Approach to studying the structure-activity relationship of native peptides. I. Structural organization of the opioid peptide Tyr-Glu-Gly-Phe-Met-Arg-Gly-Leu and its artificial analogs].
Popov EM; Akhmedov NA; Makhmudova TA
Bioorg Khim; 1992 Dec; 18(12):1454-63. PubMed ID: 1300997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
